Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2013 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Columnar cell variant thyroid gland papillary carcinoma"
Page 1
Can the tall cell variant of papillary thyroid carcinoma be distinguished from the conventional type in fine needle aspirates? A cytomorphologic study with assessment of diagnostic accuracy.
Guan H, Vandenbussche CJ, Erozan YS, Rosenthal DL, Tatsas AD, Olson MT, Zheng R, Auger M, Ali SZ. Guan H, et al. Acta Cytol. 2013;57(5):534-42. doi: 10.1159/000353823. Epub 2013 Sep 7. Acta Cytol. 2013. PMID: 24021475
OBJECTIVES: The tall cell variant of papillary thyroid carcinoma (TCV-PTC) is an aggressive variant of PTC requiring accurate cytopathologic diagnosis for early aggressive management. ...RESULTS: In a majority of the cases, the FNA direct …
OBJECTIVES: The tall cell variant of papillary thyroid carcinoma (TCV-PTC) is an aggressive variant …
Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J, Wang X, Zhang X, Li P, Hou H. Zhu J, et al. Diagn Pathol. 2015 Jul 14;10:96. doi: 10.1186/s13000-015-0346-5. Diagn Pathol. 2015. PMID: 26168921 Free PMC article.
BACKGROUND: To investigate the clinicopathological features of recurrent papillary thyroid carcinoma (PTC). METHODS: A retrospective analysis on clinical and pathological data of 34 patients with recurrent PTC was carried out. ...CONCLUSION: PTC patien …
BACKGROUND: To investigate the clinicopathological features of recurrent papillary thyroid carcinoma (PTC). METHODS: A …
Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer.
Bombardieri E, Seregni E, Villano C, Aliberti G, Mattavelli F. Bombardieri E, et al. Tumori. 2003 Sep-Oct;89(5):533-6. doi: 10.1177/030089160308900515. Tumori. 2003. PMID: 14870779 Review.
The follow-up of thyroid cancer is based on the detection of residual and recurrent thyroid carcinoma. ...In fact, rhTSH can be used during radioiodine treatment to enhance the 131I uptake by the cancer cells in particular groups of patie …
The follow-up of thyroid cancer is based on the detection of residual and recurrent thyroid carcinoma. ...In fac …
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G, Ferdeghini M, Augeri C, Villa G, Taddei GZ, Scopinaro G, Boni G, Bodei L, Rabitti C, Molinari E, Bianchi R. Mariani G, et al. Cancer Biother Radiopharm. 2000 Apr;15(2):211-7. doi: 10.1089/cbr.2000.15.211. Cancer Biother Radiopharm. 2000. PMID: 10803328
The purpose of this work was to gain clinical experience with and to identify the optimal conditions for the use of recombinant human TSH (rhTSH, commercially available as Thyrogen) in the management of patients with differentiated thyroid cancer (DTC). The s …
The purpose of this work was to gain clinical experience with and to identify the optimal conditions for the use of recombinant human …